| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cost of Revenue | $220K | — |
| R&D Expense | $4.1M | +2883.4% |
| SG&A Expense | $3.5M | +53.8% |
| Operating Income | -$7.6M | -182.5% |
| Net Income | -$8.4M | -24.5% |
| EPS (Basic) | -$0.62 | +27.1% |
| EPS (Diluted) | -$0.62 | +27.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.4M | — |
| Current Assets | $8.5M | +1067.2% |
| Total Assets | $8.5M | +994.8% |
| Current Liabilities | $827K | -38.0% |
| Total Liabilities | $827K | -86.9% |
| Stockholders' Equity | $7.7M | +238.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.5M | -193.0% |
| Capital Expenditures | $3K | +42.8% |
| Investing Cash Flow | -$3K | -42.8% |
| Financing Cash Flow | $11.9M | +860.2% |
| Free Cash Flow | -$3.5M | -192.7% |